Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 471 of 1,261
  1. US 10428082

    Triazole derivatives of melampomagnolide B and methods of use thereof

    The Regents of the University of Colorado, a body · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  2. US 10428070

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  3. US 10428119

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  4. US 10428115

    Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  5. US 10428050

    Substituted reverse pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  6. US 10428028

    HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  7. US 10428047

    MAP kinase modulators and uses thereof

    Northwestern University · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  8. US 10428056

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  9. CA 3094934

    FORMULATIONS AQUEUSES STABLES D'ANTICORPS ANTI-TAU

    ABBVIE DEUTSCHLAND [DE] · Granted Sep 26, 2019 · Expires Sep 21, 2039

    granted
  10. WO 2019180199

    COMPOSITION AQUEUSE STABLE DE PHOSPHOCRÉATINE

    ALFASIGMA SPA [IT] · Granted Sep 26, 2019 · Expires Sep 21, 2039

    granted
  11. US 10420799

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  12. US 10421798

    Factor VIII compositions and methods of making and using same

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  13. US 10421813

    Oncostatin M receptor antigen binding proteins

    Kiniksa Pharmaceuticals, GmbH · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  14. US 10421802

    Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  15. US 10421765

    Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  16. US 10420705

    Container assembly

    MEDISCA PHARMACEUTIQUE INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  17. US 10420833

    Combinatorial platform for the display of surface adjuvants and antigens

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  18. US 10420748

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  19. US 10420720

    Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  20. US 10421945

    Agents and methods to elicit anti-tumor immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  21. US 10421963

    Oligonucleotide therapy for leber congenital amaurosis

    ProQR Therapeutics II B.V. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  22. US 10421952

    Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on V-agents

    The United States of America as represented by the Secretary of the Army · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  23. US 10421980

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  24. US 10421964

    UNA oligomers and compositions for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.